AXA


New appointments to back the renewed strategy

22/02/21 -"Since his arrival, Thomas Buberl has been injecting new blood into Axa’s management. The possible arrival of Ramon Fernandez, as a member of the Board of Directors, would be good news. The ..."

Pages
50
Language
English
Published on
22/02/21
You may also be interested by these reports :
02/03/21
The net profit attributable to shareholders declined by 13% to CHF1,046m in 2020 compared to 2019 mainly impacted by two one-off effects which are ...

26/02/21
RSA had a positive year, despite the pandemic. The underlying pre-tax profit increased by 18.5% to £670m and the group’s operating result was £703m, ...

25/02/21
• Net profit attributable to shareholders decreased by 56% to €1.21bn for 2020 but was in line with the revised company guidance • COVID-19-related ...

25/02/21
Scor posted a positive Q4 20, with a jump in its net income to €99m. FY 20 net profit was €234m, -44.5% yoy. The top line was stable, at €16,368m. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO